New Approach to Immunotherapy Against Organ-specific Autoimmune Diseases with T Cell Receptor and Chemokine Receptor DNA Vaccines

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Notch signaling pathway in autoimmune diseases

By Ma Daoxin   Zhu Yuanchao   Ji Chunyan   Hou Ming  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 553-565

Informa Healthcare

Access to resources Recommend Favorite

Tissue-Specific Glucocorticoid Reactivating Enzyme, 11#946;-Hydroxysteoid Dehydrogenase Type 1 (11#946;-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 255-262

Bentham Science Publishers

Access to resources Recommend Favorite

Lysophospholipid Receptors as Potential Drug Targets in Tissue Transplantation and Autoimmune Diseases

By  

Current Pharmaceutical Design, Vol. 12, Iss. 2, 2006-01 ,pp. : 161-171

Bentham Science Publishers

Access to resources Recommend Favorite

Multivalent Compounds for Antigen-Specific B Cell Tolerance and Treatment of Autoimmune Diseases

By  

Current Medicinal Chemistry, Vol. 12, Iss. 16, 2005-08 ,pp. : 1887-1904

Bentham Science Publishers

Access to resources Recommend Favorite